Custom Capital Advisors
    Home/Resources/Biotechnology Case Study

    Case Study · Biotechnology

    Debt instead of dilution

    How a biotechnology company funded growth with debt as new contracts arrived, without selling a single share.

    Download PDFTalk to an advisor

    Biotechnology Case Study

    Debt instead of dilution

    Open PDF

    Client details have been anonymized at their request. This case study describes one client engagement and is not a prediction, projection, or guarantee of results.